229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.45%
Revenue growth exceeding 1.5x Technology median of 9.81%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
23.45%
Gross profit growth exceeding 1.5x Technology median of 9.52%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-335.93%
Negative EBIT growth while Technology median is -335.93%. Seth Klarman would check if external or internal factors caused the decline.
-335.93%
Negative operating income growth while Technology median is -335.93%. Seth Klarman would check if structural or cyclical issues are at play.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.66%
Share change of 0.66% while Technology median is zero. Walter Schloss would see if the modest difference matters long-term.
0.66%
Diluted share change of 0.66% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
88.33%
10Y revenue/share CAGR exceeding 1.5x Technology median of 31.86%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
88.33%
5Y revenue/share growth exceeding 1.5x Technology median of 31.86%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
88.33%
3Y revenue/share growth exceeding 1.5x Technology median of 31.86%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
49.07%
Equity/share CAGR exceeding 1.5x Technology median of 7.47% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
49.07%
5Y equity/share CAGR > 1.5x Technology median of 7.47%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
49.07%
3Y equity/share CAGR > 1.5x Technology median of 7.47%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
